MEDICINOVA, INC.: 10-Q filed 2014-08-13

Name: MEDICINOVA, INC.: 10-Q filed 2014-08-13
Creator: MEDICINOVA, INC.

What MEDICINOVA, INC. reported in its quarterly report filed 2014-08-13 (fiscal Q2 2014): 29 published measures, 77 facts as tagged in accession 0001193125-14-308545.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-08-13
Fiscal period: fiscal Q2 2014
Accession: 0001193125-14-308545 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEDICINOVA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-06-30	29,564,076	USD
At 2013-12-31	29,546,243	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-06-30	4,763,203	USD
At 2013-12-31	4,120,487	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-06-30	24,800,873	USD
At 2013-12-31	25,425,756	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-06-30	13,496,587	USD
At 2013-12-31	6,700,493	USD
At 2013-06-30	12,017,480	USD
At 2012-12-31	4,010,530	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	-4,474,233	USD	181
2013-01-01 to 2013-06-30	-5,205,043	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	3,523	USD	181
2013-01-01 to 2013-06-30	44,322	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	3,257	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-06-30	-305,860,947	USD
At 2013-12-31	-301,386,714	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	1,547	USD	91
2014-01-01 to 2014-06-30	3,090	USD	181
2013-04-01 to 2013-06-30	1,789	USD	91
2013-01-01 to 2013-06-30	544	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-06-30	65,686	USD
At 2013-12-31	82,414	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	231,321	USD	91
2014-01-01 to 2014-06-30	486,420	USD	181
2013-04-01 to 2013-06-30	363,586	USD	91
2013-01-01 to 2013-06-30	521,286	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-2,131,041	USD	91
2014-01-01 to 2014-06-30	-4,494,774	USD	181
2013-04-01 to 2013-06-30	-2,788,197	USD	91
2013-01-01 to 2013-06-30	-5,205,491	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-06-30	14,404,508	USD
At 2013-12-31	14,382,606	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	181	USD	91
2014-01-01 to 2014-06-30	304	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-06-30	1,096,403	USD
At 2013-12-31	460,435	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-06-30	38,029	USD
At 2013-12-31	33,894	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2014-06-30	9,600,241	USD
At 2013-12-31	9,600,241	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	2,131,041	USD	91
2014-01-01 to 2014-06-30	4,494,774	USD	181
2013-04-01 to 2013-06-30	2,788,197	USD	91
2013-01-01 to 2013-06-30	5,208,748	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	700,000	USD	91
2014-01-01 to 2014-06-30	1,400,000	USD	181
2013-04-01 to 2013-06-30	800,000	USD	91
2013-01-01 to 2013-06-30	1,300,000	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-06-30	24,146,419	shares
At 2013-12-31	22,495,443	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-06-30	330,712,810	USD
At 2013-12-31	326,868,578	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2014-06-30	-77,337	USD
At 2013-12-31	-80,803	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2014-06-30	633,569	USD
At 2013-12-31	240,148	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2014-06-30	907,921	USD
At 2013-12-31	1,673,560	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-2,120,221	USD	91
2014-01-01 to 2014-06-30	-4,471,143	USD	181
2013-04-01 to 2013-06-30	-2,784,240	USD	91
2013-01-01 to 2013-06-30	-5,204,499	USD	181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-2,120,971	USD	91
2014-01-01 to 2014-06-30	-4,470,767	USD	181
2013-04-01 to 2013-06-30	-2,789,753	USD	91
2013-01-01 to 2013-06-30	-5,215,680	USD	181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-2,121,768	USD	91
2014-01-01 to 2014-06-30	-4,474,233	USD	181
2013-04-01 to 2013-06-30	-2,786,029	USD	91
2013-01-01 to 2013-06-30	-5,205,043	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	1,295,427	USD	91
2014-01-01 to 2014-06-30	2,911,243	USD	181
2013-04-01 to 2013-06-30	1,842,092	USD	91
2013-01-01 to 2013-06-30	3,566,671	USD	181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	20,500	USD	181
2013-01-01 to 2013-06-30	67,282	USD	181

Inspect the source

Entity: MEDICINOVA, INC. / CIK 0001226616
Captured: 2026-09-20T07:46:14.294Z
SEC response SHA-256: 2ee4e761c5c78942e5c8408ca3fc8acae481ff5fcfadf88ffba53700bd842714

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001226616.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))